Compare Illumina, Inc. (ILMN) vs Tyson Foods, Inc. (TSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Tyson Foods, Inc. — how do they compare? Illumina, Inc. trades at $278.17 (market cap $39.95B), while Tyson Foods, Inc. trades at $53.43 (market cap $18.41B). The key difference: Illumina, Inc. is far larger — about 2.2× Tyson Foods, Inc.'s market cap, and Tyson Foods, Inc. pays a 3.9% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Tyson Foods, Inc. for 76 Days on average.
| ILMN | TSN | |
|---|---|---|
Market Cap | $39.95B | $18.41B |
Volume | 3,169,503 | 3,757,599 |
Sector | Health | Consumer Staples |
52-Week High | $293.69 | $68.75 |
52-Week Low | $91.00 | $50.47 |
Typical Hold Time | 83 Days | 76 Days |
Enterprise Value | $41.31B | $25.68B |
Dividend Yield | — | 3.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ILMN trades at $264.40, down 1.25% on the day, but remains near its recent 52-week high of $278.99 (Defense World, 2026-10-01). The stock has surged 94.9% year-to-date (Zacks Investment Research, 2026-09-24), supported by strong earnings beats in recent quarters and a bullish technical trend. Fundamentals show a significant turnaround, with 2025 net income reaching $850 million after prior losses, though valuation ratios like a P/E of 49.36 are elevated. The pending inclusion in the S&P 500 (PRNewsWire, 2026-09-04) adds a positive catalyst.
The outlook is positive, driven by sequencing growth, AI integration in genomics, and improved profitability. However, risks include high valuation sensitivity, cost volatility, and competitive pressures in the life sciences sector. Analyst consensus is bullish with a 54% buy rating, but the average price target of $241 suggests limited near-term upside from current levels.
Tyson Foods (TSN) trades at $52.34, up 1.24% on the day, with a mixed technical picture showing bullish overall signals but bearish moving averages. The company reported revenue of $54.44 billion in 2025, with a net income margin of 1.03%, while recent earnings show two beats and one miss. Analysts maintain a consensus buy rating with a $65.40 price target, but news highlights challenges in the beef segment and ongoing securities investigations.
The outlook for TSN is cautiously optimistic, supported by analyst confidence and dividend stability, but risks include margin pressure from beef losses, legal scrutiny, and volatile cash flows. The stock's valuation at a P/E of 32.31 appears elevated relative to modest profitability, requiring careful monitoring of execution against guidance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →
